Search
Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines.
Abstract
Increased aerobic glycolysis and de novo lipid biosynthesis are common characteristics of invasive cancers. UDP-glucuronosyltransferases (UGTs) are phase II drug metabolizing enzymes that in normal cells possess the ability to glucuronidate these lipids and speed their excretion; however, de-regulation of these enzymes in cancer cells can lead to an accumulation of bioactive lipids, which further fuels cancer progression. We hypothesize that UGT2B isoform expression is down-regulated in cancer cells and that exogenous re-introduction of these enzymes will reduce lipid content, change the cellular phenotype, and inhibit cancer cell proliferation. In this study, steady-state mRNA levels of UGT isoforms from the 2B family were measured using qPCR in 4 breast cancer and 5 pancreatic cancer cell lines. Expression plasmids for UGT2B isoforms known to glucuronidate cellular lipids, UGT2B4, 2B7, and 2B15 were transfected into MCF-7 and Panc-1 cells, and the cytotoxic effects of these enzymes were analyzed using trypan blue exclusion, annexin V/PI staining, TUNEL assays, and caspase-3 immunohistochemistry. There was a significant decrease in cell proliferation and a significant increase in the number of dead cells after transfection with each of the 3 UGT isoforms in both cell lines. Cellular lipids were also found to be significantly decreased after transfection. The results presented here support our hypothesis and emphasize the important role UGTs can play in cellular proliferation and lipid homeostasis. Evaluating the effect of UGT expression on the lipid levels in cancer cell lines can be relevant to understanding the complex regulation of cancer cells, identifying the roles of UGTs as “lipid-controllers” in cellular homeostasis, and illustrating their suitability as targets for future clinical therapy development.
Citations
-
1 7
CrossRef
-
0
Web of Science
-
2 0
Scopus
Authors (10)
-
Centdrika Dates
- . .
-
Tariq Fahmi
- . .
-
Sebastian Pyrek
- . .
-
Aiwei Yao-Borengasser
- . .
-
Stacie M. Bratton
- . .
-
Susan Kadlubar
- . .
-
Peter Mackenzie
- . .
-
Randy Haun
- . .
-
Anna Radominska-Pandya
- . .
Cite as
Full text
- Publication version
- Accepted or Published Version
- DOI:
- Digital Object Identifier (open in new tab) 10.1080/15384047.2015.1026480
- License
-
open in new tab
Keywords
Details
- Category:
- Articles
- Type:
- artykuł w czasopiśmie wyróżnionym w JCR
- Published in:
-
CANCER BIOLOGY & THERAPY
no. 16,
edition 5,
pages 714 - 723,
ISSN: 1538-4047 - Language:
- English
- Publication year:
- 2015
- Bibliographic description:
- Dates C., Fahmi T., Pyrek S., Yao-Borengasser A., Borowa-Mazgaj B., Bratton S., Kadlubar S., Mackenzie P., Haun R., Radominska-Pandya A.: Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines.// CANCER BIOLOGY & THERAPY. -Vol. 16, iss. 5 (2015), s.714-723
- DOI:
- Digital Object Identifier (open in new tab) 10.1080/15384047.2015.1026480
- Verified by:
- Gdańsk University of Technology
seen 127 times
Recommended for you
PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells
- J. Węsierska-Gądek,
- N. Zulehner,
- F. Ferk
- + 3 authors